R-packages - best practices and useful tools

R-packages - best practices and useful tools

Author: Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry March 24, 2025 Duration: 20:55
In this episode, I’m joined once again by Daniel Sabanés Bové to talk all about R packages—why they’re so useful, when to create one, and how to do it effectively. Whether you’re just starting out with writing reusable functions or thinking about building a more robust and reusable R package, you’ll find plenty of hands-on advice in our discussion. Daniel shares his experiences from working at Roche, Google, and now through his consultancy, Arconis. We dive into everything from writing clean and consistent code, to testing, documenting, and even promoting your package in the open-source world. What You’ll Learn in This Episode:

Hosted by Alexander Schacht and Benjamin Piske, both practicing biometricians and leaders within the pharmaceutical industry, The Effective Statistician-in association with PSI is a conversation about the practical realities of the profession. This isn't a theoretical lecture series; it's a resource built from the ground up by statisticians who navigate the same challenges you do every day. The discussions focus on actionable strategies for increasing your influence and efficiency, whether you're analyzing data, presenting findings, or guiding a team. You'll hear perspectives on developing leadership qualities even without a formal management title, and gain insight into current debates within the scientific and regulatory communities. The aim is to provide context for the health sector's evolving landscape, translating complex industry dynamics into relevant knowledge for your work. Tune in for a candid exploration of what it means to be a modern statistician, designed to help you refine your approach and achieve a more significant impact. This podcast serves as a professional toolkit, created in association with PSI (Promoting Statistical Insight), for statisticians at any career stage looking to deepen their expertise and navigate their roles with greater confidence and clarity.
Author: Language: English Episodes: 100

The Effective Statistician - in association with PSI
Podcast Episodes
External control arms - how to get to a good one [not-audio_url] [/not-audio_url]

Duration: 26:51
In this episode, I’m joined by Deepa Jahagirdar, Associate Research Principal at Cytel, to explore what it really takes to build a good external control arm (ECA). Deepa brings a fascinating background from social epidem…
Top 9: Non-parametric analyses - much more than just the Wilcoxon test! [not-audio_url] [/not-audio_url]

Duration: 40:19
Why this episode made our all-time Top 9: If you’ve ever thought “non-parametric = Wilcoxon/Mann-Whitney and that’s it,” this conversation will happily destroy that myth. Frank shows how rank-based methods unlock rigorou…
Introduction to adaptive designs and ICH E20 [not-audio_url] [/not-audio_url]

Duration: 29:36
In this episode, I’m joined once again by my friend and frequent guest, Kaspar Rufibach, to talk about a topic that’s been around for decades but is gaining fresh attention thanks to the new ICH E20 draft guideline—adapt…
Top 8: The Single Arm Studies and What are the Alternatives? [not-audio_url] [/not-audio_url]

Duration: 45:32
I’m excited to reshare one of our most-played conversations—the one where Norwegian regulator/HTA leader Anja Schiel and I get very practical about when single-arm trials fail decision-makers and what comparative, smarte…
Top 6: What is EU HTA and why should statisticians care? [not-audio_url] [/not-audio_url]

Duration: 36:08
This is one of our most downloaded episodes ever, and I’m excited to bring it back in this replay. In this conversation, I spoke with Lara Wolfson (MSD) and Anders Gorst-Rasmussen (Novo Nordisk) about EU HTA (European Un…
Top 5: The analysis of adverse events done right [not-audio_url] [/not-audio_url]

Duration: 52:45
We’re bringing back one of our most downloaded episodes ever – a deep dive into how adverse events should be analyzed properly. This conversation with Jan Beyersmann and Kaspar Rufibach is packed with methodological insi…